Absorption |
Blood-Brain Barrier | BBB+ | 0.9779 |
Human Intestinal Absorption | HIA+ | 0.9804 |
Caco-2 Permeability | Caco2+ | 0.5727 |
P-glycoprotein Substrate | Substrate | 0.8336 |
P-glycoprotein Inhibitor | Inhibitor | 0.8969 |
Inhibitor | 0.7848 |
Renal Organic Cation Transporter | Inhibitor | 0.5989 |
Distribution |
Subcellular localization | Lysosome | 0.4704 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7619 |
CYP450 2D6 Substrate | Non-substrate | 0.6056 |
CYP450 3A4 Substrate | Non-substrate | 0.5126 |
CYP450 1A2 Inhibitor | Inhibitor | 0.7497 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.6261 |
CYP450 2D6 Inhibitor | Inhibitor | 0.7317 |
CYP450 2C19 Inhibitor | Inhibitor | 0.6870 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.6222 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8952 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8844 |
Inhibitor | 0.6767 |
AMES Toxicity | Non AMES toxic | 0.8060 |
Carcinogens | Non-carcinogens | 0.9161 |
Fish Toxicity | High FHMT | 0.9717 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9871 |
Honey Bee Toxicity | Low HBT | 0.8482 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | II | 0.4787 |
Carcinogenicity (Three-class) | Non-required | 0.6260 |